Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6K Hold
49
﹤0.01% 1876
2026
Q1
$8.98K Sell
49
-36
-42% -$6.63K ﹤0.01% 1959
2025
Q4
$15K Sell
85
-18
-17% -$2.94K ﹤0.01% 1887
2025
Q3
$14.4K Sell
103
-51
-33% -$6.89K ﹤0.01% 1886
2025
Q2
$19K Sell
154
-103
-40% -$12.8K ﹤0.01% 1723
2025
Q1
$35K Buy
+257
New +$36.7K ﹤0.01% 1274
2024
Q4
Sell
-460
Closed -$89K 1345
2024
Q3
$89K Sell
460
-290
-39% -$60.7K 0.01% 1017
2024
Q2
$173K Buy
750
+40
+6% +$8.69K 0.02% 800
2024
Q1
$153K Buy
710
+93
+15% +$21.8K 0.01% 828
2023
Q4
$159K Buy
617
+189
+44% +$46.4K 0.02% 810
2023
Q3
$110K Buy
+428
New +$114K 0.01% 902

Other funds holding BIIB

NBC Securities's BIIB Position: Q2 2026 in Review

NBC Securities held its Biogen (BIIB) position steady in Q2 2026 at 49 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1876.

NBC Securities first reported a position in BIIB in Q3 2023 and has held it in 11 quarters since. The position peaked at $173K in Q2 2024. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • NBC Securities held 49 shares of Biogen worth $10.6K as of Q2 2026.
  • NBC Securities left its Biogen share count unchanged in Q2 2026.
  • Biogen made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1876 holding.
  • NBC Securities first reported a position in Biogen in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's Biogen position peaked at $173K in Q2 2024.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.